Cleared Traditional

K943787 - AURATEK FDP

K943787 is an FDA 510(k) clearance for AURATEK FDP, manufactured by Organon Teknika Corp.. The device is a Class 2 Hematology device with product code DAP cleared through the Traditional 510(k) pathway after a 48-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1994
Decision
48d
Days
Class 2
Risk

K943787 is an FDA 510(k) clearance for the AURATEK FDP. Classified as Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (product code DAP), Class II - Special Controls.

Submitted by Organon Teknika Corp. (Durham, US). The FDA issued a Cleared decision on September 20, 1994 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Organon Teknika Corp. devices

FDA 510(k) Submission Details - K943787

510(k) Number K943787 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 1994
Decision Date September 20, 1994
Days to Decision 48 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 113d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DAP Device Classification - Class 2, Special Controls

Product Code DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 44
Devices cleared under the same product code (DAP) and FDA review panel - the closest regulatory comparables to K943787.
IL TEST D-DIMER
K972696 · Instrumentation Laboratory CO · Nov 1997
STA-LIATEST D-DI TEST KIT
K964728 · American Bioproducts Co. · Jun 1997
STA D-DI CALIBRATOR KIT
K964718 · American Bioproducts Co. · May 1997
FIBRINOSTIKA TDP MICROELISA SYSTEM
K915698 · Organon Teknika Corp. · Aug 1992
FDP PLASMA TEST KIT
K920943 · American Bioproducts Co. · Jul 1992
D-DIMER WELLCOTEST (HA10)
K915203 · Wellcome Diagnostics · Jan 1992